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Abstract 
Background: Reduction in autonomic tone as measured by heart rate variability (HRV) has 
been associated with various inflammatory conditions including reflux disease. The nature of 
and permanence of this damage have not been fully assessed 
Methods: 14 individuals with non-erosive reflux disease (NERD) and 10 individuals with 
erosive reflux disease (ERD) as identified on endoscopy were assessed for HRV prior to 
starting a course of proton pump inhibitor (PPI) therapy and 8 weeks from the start of PPI 
therapy.  
Key results: Reflux symptoms were significantly improved by PPI therapy (P=0.001), with 
no significant difference in reflux symptoms between the NERD and ERD groups either 
before (P=0.45) or following therapy (P=0.17). The ERD group displayed reduced HRV prior 
to PPI therapy as compared with a non-symptomatic group. There was significant 
improvement of HRV resulting from PPI therapy in the ERD group as measured by 
inspiration/ expiration ratio on forced breathing (P=0.02), Valsalva ratio (P=0.03) and 
extended metronome guided breathing at 6 breaths per minute (P=0.03). While a similar 
pattern was seen in the NERD group, the effects were not as strong and did not reach 
statistical significance. 
Conclusions and Inferences: The results are consistent with a growing body of evidence 
that cardiac autonomic neuropathy as measured by HRV is associated with gastro-esophageal 
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reflux disease and also suggest that successful treatment of the inflammation can lead to 
reversal of the deterioration of autonomic tone associated with that inflammation. 
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Key Messages: 
• Take-Home Message: Inflammatory reflux disease is deleterious to autonomic 
function but the effects can be reversed by successful treatment with PPI therapy 
• Aims: Establish if autonomic tone is adversely affected by inflammatory reflux 
disease and if autonomic tone responds to healing PPI therapy 
• Basic Methodology: 14 volunteers with non-erosive esophagitis and 10 with erosive 
esophagitis were assessed for heart rate variability prior to and 8 weeks following 
starting PPI therapy 
• Results: Erosive esophagitis volunteers had reduced HRV as compared with a group 
of volunteers with no history of reflux. Volunteers with erosive esophagitis displayed 
significantly improved HRV following PPI therapy. Volunteers with non-erosive 
esophagitis had less pronounced changes that did not reach statistical significance. 
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INTRODUCTION 
Symptoms of gastro-esophageal reflux disease (GERD) are very common, affecting 8% to 
25% of the population of Europe, (1). Acid reflux causes a range of symptoms including 
heartburn, epigastric pain, retrosternal pain, belching, dysphagia and regurgitation (1,2).  
Proton Pump Inhibitor (PPI) therapy is a common treatment for GERD related symptoms. 
Caro et al (3) performed a Meta-analysis of 53 studies involving acute PPI therapy and 
maintenance PPI therapy. These studies looked at the PPI healing rates for erosive 
esophagitis at eight weeks. All PPI’s showed a greater degree of healing esophagitis at eight 
weeks than H2-receptor antagonist or placebo and all maintained similar rates of symptom 
control 
 
Erosive esophagitis is inflammation of the lining of the esophagus resulting from GERD. 
Esophagitis is graded endoscopically according to its severity using the Los Angeles 
Classification (4). The majority of patients with reflux symptoms will have some esophagitis 
visible on endoscopy, described as erosive reflux disease (ERD). However a significant 
proportion of patients with significant reflux symptoms have no obvious esophagitis on 
endoscopy, this group being described as having non-erosive reflux disease (NERD) (5). 
 
Cardiovascular autonomic function is known to be significantly and permanently 
compromised in a number of diseases, notably diabetes Parkinson’s disease and multi-system 
atrophy (6). Significant autonomic failure is accompanied by a range of symptoms including 
dizziness, loss of consciousness, diarrhoea, excessive sweating and loss of sexual function 
(7). It is also associated with a large increase in risk of sudden cardiac death (8, 9).  
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Previous research has shown that the performance of the autonomic nervous system is 
significantly attenuated in diabetics compared with a healthy age-matched cohort in the 
absence of typical symptoms of autonomic failure (10). Various studies have noted 
deterioration in autonomic regulation resulting from various inflammatory conditions 
including pneumonia (11), and even resulting from the minor inflammatory response to the 
influenza vaccine (12). Cardiovascular autonomic function appears to be adversely affected 
by reflux disease, though the extent of deterioration differs significantly between patients 
with and without erosive esophagitis (13).  
 
This study aimed to examine autonomic tone in patients with mild erosive reflux 
(esophagitis) disease (ERD) and those with non-erosive reflux disease (NERD) and assess the 
change in autonomic tone in the two groups resulting from an eight week healing dose of PPI 
therapy to see if treatment for GERD can reverse any deterioration in autonomic tone 
observed. 
 
MATERIALS AND METHODS 
Patients aged 18 – 80 years old attending for routine gastroscopy (OGD) in the Endoscopy 
Department of Poole Hospital NHS Foundation Trust were considered for inclusion in this 
project and approached if they were considered to have a high clinical probability of GERD. 
This was assessed on the basis of having typical reflux symptoms or non-cardiac chest pain, 
have some endoscopic indication for reflux (GERD, lax sphincter or hiatus hernia) and their 
treatment plan following endoscopy to include a prescription for PPI therapy. Patients were 
excluded for consideration if they had severe (grade C or D) esophagitis or Barrett’s Disease 
or any other upper GI pathology including gastritis, or if they had used PPI therapy for a 
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significant time period.  Patients were also excluded if they had Diabetes Mellitus, heart 
disease or any acute or chronic inflammatory condition apart from esophagitis.  
 
We recruited 24 participants in total between September 2010 and November 2013, 14 
having no endoscopically identifiable esophagitis (NERD group) and 10 with grade A or B 
esophagitis (ERD group). The demographic details are summarised in Table 1. 
 
Volunteers were assessed for autonomic function prior to initiation of their PPI therapy and at 
least 8 weeks following initiation of PPI therapy. Volunteers completed a standard GERD 
impact questionnaire at the time of autonomic assessment on both visits 
(http://www.epgpatientdirect.org/docs/gerd/questionnaire_gerd-impact-scale[1].pdf).  
 
Autonomic function testing was performed after the methods described in Perring and Jones 
(12). A ProComp Infiniti Biosignal Recorder (Thought Technology, Montreal, Canada) was 
used to collect ECG and chest wall plethysmography signals from the volunteers. Data was 
collected in real-time at 1024Hz for the ECG data and 256Hz for the chest wall 
plethysmography data. Data was transferred to a PC via an optical fibre interface and 
recorded using in-house developed software written in Visual Basic 6 (Microsoft 
Corporation). 
  
The volunteers were required not to eat anything and to refrain from caffeine and nicotine for 
at least 3 hours prior to the assessment. Where possible the volunteers were re-assessed at the 
same time of day to minimise any diurnal variation.  
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The following sequence of provocations was used to assess autonomic cardiovascular 
reflexes: 
1 An extended rest period (5 min). 
2 A trial period of at least two cycles of deep breathing at six breaths per min. 
3 Valsalva Manoeuvre (open glottis, pressure achieved >20 mmHg, maintained for 10 s). 
4 Maximal hand grip (10 s squeeze without breath hold, repeated after 30 s). 
5 Two minutes of metronome-guided deep breathing at six breaths per minute. 
6. Lying standing manoeuvre (ratio of heart rate at beat 15 following standing over heart rate 
at beat 30 following standing)  
 
Analysis included the following: 
1. Extended resting heart rate variability (SDNN, PNN50 and low frequency/ high frequency 
(LF/HF) ratio. 
2. Analysis of the provocations originally proposed by Ewing et al (14) and detailed in 
Mathias and Bannister (15). 
• Heart rate difference between maximum and minimum heart rate breathing at 5 
seconds inhalation, 5 seconds exhalation at maximum depth, in beats per minute 
(bpm) (I/E Diff) 
• Ratio of heart rate during maximal handgrip to heart rate during resting 
• Ratio of maximum heart rate following standing (approximately 15 beats after 
standing) to minimum heart rate following standing (approximately 30 beats 
following standing) 
3. Analysis of heart rate variability during 2 minutes of metronome guided breathing at 6 
breaths per minute. Assessment of the correlation of heart rate and chest wall movement as 
well as amplitude of heart rate variation in temporal and frequency space, resulting in a 
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combined parameter (DEV) representing the number of standard deviations outside of normal 
age matched values as described in Perring and Jones (12). 
 
Ethical approval was sought and approval was given by Hampshire Research Ethics 
Committee (10/H0504/31)  
 
RESULTS 
Comparison of Symptom Responses in the Two Sample Groups 
Analysis of the results of the GERD Impact scale using a paired t-test shows a dramatic 
statistical difference (p=<0.001) in the scores before and after eight weeks of PPI therapy, 
indicating a dramatic and consistent improvement in GERD symptoms  resulting from PPI 
therapy. There was no significant difference between the symptom impact scores of the ERD 
and NERD groups, either before or after 8 weeks of PPI therapy (P=0.45 and P=0.17 
respectively)  
 
Comparison of initial HRV in reflux group versus normal volunteer group 
Measurement parameters for the initial (non-treated) NERD/ERD groups were compared 
with data collected from 71 normal volunteers prior to influenza vaccine reported in a 
previous paper by Perring and Jones (12). There was no significant difference in age between 
the previous normal group of 71 individuals and the ERD, NERD or combined groups. The 
results of this data comparison using independent t-testing suggest that there does appear to 
be a statistically significant difference in many of the measures of HRV between a normal 
healthy volunteer group from a previous study and the ERD group, with the HRV parameters 
lower in the ERD group than the normal group (see table 2). There did appear to be a similar 
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trend to lower HRV in the NERD group, but the differences with the normal group did not 
reach statistical significance in the majority of HRV parameters assessed. 
 
Comparison of HRV prior to and following PPI treatment 
Measurement parameters for assessment of HRV were compared prior to initiation of PPI 
treatment and following 8 weeks of PPI treatment for both the NERD and ERD groups. There 
was a generalised increase in HRV values for both groups between the two visits indicating 
an improvement in autonomic tone, but only for the ERD group was there statistically 
significant improvement for 3 parameters of HRV. Analysis of the data for the NERD group 
showed no significant change in autonomic tone after eight weeks of PPI therapy. 
 
DISCUSSION  
We remain circumspect about the weight of these results due to the small number of subjects 
recruited to both groups and the lack of consistent changes across the full range of parameters 
measured. However this being said, the study does still suggest a tendency for individuals 
with symptoms of reflux disease to have reduced HRV consistent with some reduction in 
autonomic tone as compared with a healthy group and that furthermore the effect is strongest 
in individuals with macroscopic inflammation identified on gastrography (ERD). This finding 
is in keeping with research by Lee et al (16) who found a difference in autonomic tone in the 
ERD group compared with the NERD group. Chen (13) also found that autonomic function 
appears to differ significantly between the two groups, with spectral analysis of heart rate 
variability significantly reduced in the high frequency power band in patients with erosive 
esophagitis. In contrast the reported symptom impact scores of the two groups did not 
significantly differ between the NERD and ERD groups at baseline assessment.  
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The results of this study also suggest a significant improvement in several parameters of 
HRV following a healing treatment of PPI therapy in individuals with ERD. This statistically 
significant improvement in HRV was not observed in the NERD group. This is in spite of 
there being no difference between the reported symptom impact scores in the two groups 
following PPI therapy, indicating that both groups recorded a similar symptomatic benefit 
from the PPI therapy. 
 
As a result of this study we concur with Lee et al (16) that “It is the structural state of the 
oesophagus and not the symptomology which dictates the autonomic function status.”  
 
There is a growing weight of evidence that deterioration in autonomic reflexes is associated 
with inflammatory conditions, the suggested route of interaction being via the cholinergic 
anti-inflammatory pathway (17).  This study further suggests that amelioration of the 
inflammatory condition, in this case by treatment of acid reflux, can reverse the deterioration 
in autonomic tone. There is clear evidence that deterioration in autonomic responses with 
type 2 diabetes is associated with significant symptoms and a rise in cardiovascular risk and 
risk of sudden death (18). It is at present unclear but entirely possible that minor deterioration 
in autonomic reflexes as are associated with reflux disease may be associated with a smaller 
but still raised risk of cardiac events.  
 
Given the reversible nature of the HRV changes seen in this study it could be argued that 
there may be justification for the treatment of GERD patients, particularly those who are 
elderly and/or with diabetes, with anti-inflammatory medication alongside conventional PPI 
therapy to reduce the impact on the autonomic nervous system.  
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This trial did not include individuals with severe inflammatory reflux disease (grades C or D 
esophagitis or Barrett’s Disease), which we suspect would have more severe deterioration of 
autonomic tone and whose symptoms may in part be aggravated by symptoms associated 
with impaired autonomic reflexes. 
 
CONCLUSIONS 
This paper does add weight to other published evidence that mild esophagitis is associated 
with a minor deterioration in autonomic reflexes. Furthermore the results support the 
proposition that this mild deterioration in autonomic performance is reversed by treatment of 
esophagitis with PPI therapy.  
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Table 1. Demographic details of sample groups 
 Total NERD ERD 
Number of volunteers 24 14 10 
Age range 26 - 72 26 - 65 42 - 72 
Age (mean+/-SD) 50.1+/- 11.3 49.1 (13.6) 51.6 (9.5) 
Gender M:F 14:10 8:5 6:5 
 
 
Table 2. Comparison of initial HRV in reflux group versus normal volunteer group 
 Value for 
Normal Group  
mean (SD) N=71 
Value for ERD 
Group  
mean (SD) N=10 




t (P Val) 
Age (years) 48.7 (11.9) 51.2 (9.5) 0.6 (0.55) 50.8 (13.6) 0.54 (0.58) 
Resting Measures 
Resting Heart Rate 
(bpm) 
73.45 (10.91) 70.6 (10.01) 0.65 (0.52) 67.1 (9.8) 1.19 (0.06) 
SDNN (ms) 46.66 (25.8) 43.6 (22.5) 
 
-0.18 (0.86) 53.2 (34.5) 
 
- 2.12 (0.04) 
PNN50 (%) 8.80 (11.61) 3.5 (2.9) 
 
3.3  (0.02) 3.7 (6.1) 
 
-0.02 (0.85) 
LF/HF Ratio 1.06 (0.07) 3.6 (1.6) 
 
-8.12 (0.001) 4.11 (2.24) 
 
-9.95 (0.001) 
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Ewing Provocation Tests 
I/E Diff (bpm) 14.18 (7.73) 9.7 (4.5) 1.66 (0.02) 13.1 (8.1) 
 
0.22 (0.82) 
Valsalva (ratio) 1.33 (0.18) 1.2 (0.1) 1.79 (0.06) 1.35 (0.3) 
 
-0.79 (0.43) 
Hand grip (ratio) 1.17 (0.09) 1.1  (0.1) 1.33 (0.05) 1.1 (0.1) 
 
1.51 (0.13) 
Metronome Breathing Analysis 
DEV (SD’s from age-
matched norm) 
0.29 (1.2) -0.25 (1.4) 1.32 (0.19) 0.38 (1.2) 0.84 (0.40) 
 
 
Table 3 Changes in HRV parameters during Ewing assessment and metronome guide breathing for the 
ERD and NERD group prior to and following eight weeks on PPI therapy.  
 ERD Group (N=10) NERD Group (N=14) 







(P Val)  
 







(P Val)  
 
GERD Impact Scale 
Average scores 12.2 (4.6) 3.3 (3.9) 5.9  (0.001)  13.7 (4.8) 5.3 (4.7) 7.7  (0.001) 
Resting Measures 
Resting HR (bpm) 70.6 (9.6) 74.7 (10.1) 2.3  (0.06)  67.1 (9.8) 67.3 (10.1) 0.8  (0.43) 
SDNN (ms) 43.6 (22.5) 48.7 (18.4) 2.2  (0.06)  53.2 (34.5) 53.5 (24.1) 1.1  (0.28) 
PNN50 (%) 3.5 (2.9) 2.86 (2.84) 1.9  (0.08)  3.7 (6.1) 2.8 (2.7) 1.9  (0.08) 
LF/HF Ratio 3.6 (1.6) 3.55 (1.8) 1.4  (0.18)  4.11 (2.24) 4.13 (2.27) 0.8  (0.44) 
Ewing Provocation Tests 
I/E Diff (bpm) 9.7 (4.5) 13.3 (5.5) 2.84  (0.02)  13.1 (8.1) 15.1 (8.8) 1.9  (0.08) 
Valsalva (ratio) 1.2 (0.1) 1.3 (0.2) 2.5  (0.03)  1.35 (0.3) 1.38 (0.2) 1.17  (0.26) 
Hand grip (ratio) 1.1 (0.1) 1.1 (0.1) 0.1  (0.91) 1.1 (0.1) 1.15 (0.1) 1.5  (0.15) 
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Lying / Standing (ratio) 1.0 (0.1) 1.1 (0.3) 2.1  (0.06) 1.1 (0.16) 1.0 (0.38) 0.2  (0.81) 
Metronome Breathing Analysis 
DEV -0.25 (1.4) 0.44 (1.3) 2.5  (0.03) 0.38 (1.2) 0.56 (1.4) 1.09  (0.29) 
 
 
